https://www.thecarlatreport.com/rss en-us Two new advances may help us detect Alzheimer’s disease and other dementias. Two new advances may help us detect Alzheimer’s disease and other dementias.

]]> http://www.thecarlatreport.com/articles/4642 Mon, 01 Jan 2024 00:00:00 -0500 https://www.thecarlatreport.com/articles/4642-advances-in-alzheimers-diagnosis-airamed-and-labcorp Consider other treatments before reaching for brexpiprazole, even though it’s FDA-approved to treat agitation in dementia due to Alzheimer’s disease. Consider other treatments before reaching for brexpiprazole, even though it’s FDA-approved to treat agitation in dementia due to Alzheimer’s disease. 

]]> http://www.thecarlatreport.com/articles/4531 Tue, 31 Oct 2023 00:00:00 -0400 https://www.thecarlatreport.com/articles/4531-brexpiprazole In July 2013, the FDA approved the SNRI Fetzima (levomilnacipran) for major depressive disorder (MDD) in adults (Forest Laboratories, Inc). The efficacy of Fetzima at doses 40 mg to 120 mg once daily was established in three, eight-week, randomized, double-blind, placebo-controlled studies in adults diagnosed MDD. http://www.thecarlatreport.com/articles/2039 Sun, 01 Sep 2013 01:01:51 -0400 https://www.thecarlatreport.com/articles/2039-fetzima-approved-for-depression